These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 38411268

  • 1. Prescribing Practices and Barriers of Biologics for Chronic Rhinosinusitis Amongst Otolaryngologists.
    Bell CM, Thamboo AV, Monteiro E, Yip J.
    Laryngoscope; 2024 Aug; 134(8):3493-3498. PubMed ID: 38411268
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA, Senior BA.
    J Otolaryngol Head Neck Surg; 2023 Sep 28; 52(1):64. PubMed ID: 37759322
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis.
    Thamboo A, Kilty S, Witterick I, Chan Y, Chin CJ, Janjua A, Javer A, Lee J, Monterio E, Rotenberg B, Scott J, Smith K, Sommer DD, Sowerby L, Tewfik M, Wright E, Desrosiers M.
    J Otolaryngol Head Neck Surg; 2021 Mar 09; 50(1):15. PubMed ID: 33750471
    [Abstract] [Full Text] [Related]

  • 6. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.
    Brown WC, Senior B.
    Curr Allergy Asthma Rep; 2020 Apr 22; 20(6):16. PubMed ID: 32323067
    [Abstract] [Full Text] [Related]

  • 7. Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey.
    Favier V, Daveau C, Carsuzaa F, Fieux M, Vandersteen C, Castillo L, Papon JF, de Gabory L, Saroul N, Verillaud B, Rumeau C, Jankowski R, Michel J, de Bonnecaze G, Lecanu JB, Coste A, Béquignon E, Malard O, Mortuaire G.
    BMJ Open; 2024 May 15; 14(5):e083112. PubMed ID: 38749694
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Results of a survey on the current management of chronic rhinosinusitis with nasal polyps in Germany].
    Deuss E, Becker S, Meyer M, Hussain T, Eckrich J, Lang S, Klimek L, Ernst B.
    Laryngorhinootologie; 2024 Sep 15; 103(9):646-654. PubMed ID: 38565182
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduction in healthcare resource use through 24 months following sinus surgery with steroid-eluting implants in chronic rhinosinusitis patients with and without nasal polyps: a real-world study.
    Hoffman V, Mulder K, Topuria I, Gawlicka AK, Kallman JE.
    Curr Med Res Opin; 2023 Dec 15; 39(12):1613-1619. PubMed ID: 36994626
    [Abstract] [Full Text] [Related]

  • 16. Biologics in chronic rhinosinusitis with nasal polyposis.
    Laidlaw TM, Buchheit KM.
    Ann Allergy Asthma Immunol; 2020 Apr 15; 124(4):326-332. PubMed ID: 31830587
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Role of Biologics in the Treatment of Chronic Rhinosinusitis.
    Haloob N, Karamali K, Hopkins C.
    BioDrugs; 2023 Jul 15; 37(4):477-487. PubMed ID: 37318659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.